Tessara Therapeutics
Tessara Therapeutics Pty Ltd is a biotechnology company focused on neural drug discovery and regenerative medicine using its proprietary RealBrain® 3D micro-tissue platform. The company develops physiologically relevant, reproducible, and high-throughput 3D human brain models that mimic the complexity of the human brain, including heterogeneous neural networks and natural extracellular matrix. Tessara's RealBrain® technology supports drug discovery with scalable, automated manufacturing and offers disease-specific models such as Alzheimer's, traumatic brain injury, and developmental brain processes. The company also explores regenerative medicine applications for neurological diseases using these micro-tissues as functional implants. Tessara operates through innovation, partnerships, and interdisciplinary convergence, combining neuroscience, biomaterials, data science, automation, and AI to address unmet neurological needs. The company is based in Australia and led by experienced executives with strong backgrounds in neuroscience, biotech commercialization, and regenerative medicine.
Tessara Therapeutics
Tessara Therapeutics Pty Ltd is a biotechnology company focused on neural drug discovery and regenerative medicine using its proprietary RealBrain® 3D micro-tissue platform. The company develops physiologically relevant, reproducible, and high-throughput 3D human brain models that mimic the complexity of the human brain, including heterogeneous neural networks and natural extracellular matrix. Tessara's RealBrain® technology supports drug discovery with scalable, automated manufacturing and offers disease-specific models such as Alzheimer's, traumatic brain injury, and developmental brain processes. The company also explores regenerative medicine applications for neurological diseases using these micro-tissues as functional implants. Tessara operates through innovation, partnerships, and interdisciplinary convergence, combining neuroscience, biomaterials, data science, automation, and AI to address unmet neurological needs. The company is based in Australia and led by experienced executives with strong backgrounds in neuroscience, biotech commercialization, and regenerative medicine.